_________ false

כיטוב פארמה בע"מ	2 352
KITOV PHARMA LTD
Corporation no: 520031238	10994

	Israel Securities Authority			Tel Aviv Stock Exchange		C004 ( Public )		Reported via MAGNA:	30/03/2019
	www.isa.gov.il			www.tase.co.il				Reference:	2019-02-029197	Time of broadcast: 20:57 20:54:00

Immediate report on other matter

Don't use this form if there is more adequate one

Please note that in the case of delayed publication of report, no changes will be allowed after the form is submitted.

Delay the publication of a report _________ _________

1. The delay of the report can be done up to 72 hours maximum from the date of filling out the form.

2. Attention that in accordance with the provisions of the law, the reporting date must be simultaneous with the report in the foreign exchange.

Form S-8 Registration Statement Under the Securities Act of 1933 KITOV PHARMA LTD. 2016 EQUITY-BASED INCENTIVE PLAN החברה הגישה לרשות ניירות ערך בארה"ב מסמך לרישום ניירות ערך שתנפיק במסגרת תכנית אופציות לעובדים. דוח זה אינו מהווה הצעה או שידול להציע הצעות לרכישת ניירות הערך או למכירת ניירות הערך, ולא יכולה להיות כל מכירת ניירות הערך בכל מדינה או תחום שיפוט, בו כל הצעה, שידול או מכירה הינה עלולה להיות בלתי חוקית לפני הרישום או קבלת האישורים בהתאם לדיני ניירות ערך בכל מדינה או תחום שיפוט

Attached file fs82019_kitovpharmaltdAS-FILED_isa.pdf

The public submission by the Company to the Israel Securities Authority and the Tel Aviv Stock Exchange of a copy of a U.S. Registration Statement on Form S-8 filed with the United States Securities Exchange Commission under the Securities Act of 1933 should not be deemed an admission by the Company that such public submission is required of the Company under the Securities Law 5728-1968 and the Securities Regulations (Periodic and Immediate Reports of Foreign Corporation) 5761-2000, nor an admission by the Company that this public submission is necessarily being delivered pursuant to the aforesaid laws and regulations.
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Stock Exchange/Market: NASDAQ CM	Date of revision of form structure: 19/02/2019
Address: Menachem Begin St, Azrieli Towers Round Tower 132 , Tel Aviv 6701101   , Israel Tel: 03-9333121 , Fax: 03-5097196
E-mail address: info@kitovpharma.com   Company site: www.kitovpharma.com
Previous names of reporting entity: KITOV PHARMACEUTICALS HOLDINGS LTD, MAINROM LINE LOGISTICS LTD, ORLINE DEVELOPMENT AND INVESTMENT LTD, KADURY & HAI (MOLET) ASSETS & INVESTMENTS LTD,
Name of the Signatory: BEN-TZVI ABRAHAM SHLOMO Position of Signatory in the reporting corporation: Chief Legal Officer & Secretary Name of Employer Company:
Address: Menachem Begin St, Azrieli Towers Round Tower 132 , Tel Aviv 6701101 Telephone: 03-9333121 Facsimile: 03-5097196 E-mail: avraham@kitovpharma.com 1
Israel